Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 1/2016

01.02.2016 | Research Article

Chronotherapy in practice: the perspective of the community pharmacist

verfasst von: Gagandeep Kaur, Yuh-Lin Gan, Craig L Phillips, Keith Wong, Bandana Saini

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Background Optimising the time of drug administration in alignment with circadian rhythms to enhance the clinical effect or minimise/avoid adverse effects is referred to as chronotherapy. Pharmacists have a key role in providing medicine related information, including counselling about the optimal time for medication administration. Where applicable, the principles of chronotherapy should underlie this aspect of medication counselling. Despite significant developments in the science of chronotherapy for specific pharmacological treatments, the perspective of pharmacists about their understanding and application of these principles in practice has not been explored. Objective To explore community pharmacist’s viewpoints about and experience with the application of chronotherapy principles in practice. Setting Community pharmacies within metropolitan Sydney in New South Wales, Australia. Methods Semi-structured, face to face interviews with a convenience sample of community pharmacists were conducted. All interviews were audio-recorded, transcribed verbatim and thematically analyzed using a ‘grounded theory’ approach, given the novelty of this area. Main outcome measure Community pharmacists’ awareness, current practice and future practice support requirements about the principles of chronotherapy. Results Twenty-five semi-structured interviews were conducted. Most participants reported encountering cases where clinical decision making about suggesting appropriate times of drug administration to patients was needed. Their approach was mainly pragmatic rather than based on theoretical principles of circadian variation in drug disposition or on current or emerging evidence; thus there was an evidence practice chasm in some cases. However, most participants believed they have an important role to play in counselling patients about optimal administration times and were willing to enact such roles or acquire skills/competence in this area. Conclusion Community pharmacists contribute to the safe and effective use of medications in providing the patients with information on optimal timing of drug administration during counselling. Further education, practical training and access to information may help pharmacists in translating principles of chronotherapy into the practice.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Ortiz M, Cecere R, Gallagher R. Impact of the Mirixa Program on patient compliance to therapy. Aust Pharm. 2011;30(3):244. Ortiz M, Cecere R, Gallagher R. Impact of the Mirixa Program on patient compliance to therapy. Aust Pharm. 2011;30(3):244.
2.
Zurück zum Zitat Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):825–7.CrossRefPubMed Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):825–7.CrossRefPubMed
3.
Zurück zum Zitat Sajan J, Cinu T, Chacko A, Litty J, Jaseeda T. Chronotherapeutics and chronotherapeutic drug delivery systems. Trop J Pharm Res. 2009;8(5):467–75.CrossRef Sajan J, Cinu T, Chacko A, Litty J, Jaseeda T. Chronotherapeutics and chronotherapeutic drug delivery systems. Trop J Pharm Res. 2009;8(5):467–75.CrossRef
4.
Zurück zum Zitat Smolensky MH, Siegel RA, Haus E, Hermida RC, Portaluppi F. Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ, editors. Fundamentals and applications of controlled release drug delivery. Advances in delivery science and technology. New York: Springer; 2012. p. 359–443.CrossRef Smolensky MH, Siegel RA, Haus E, Hermida RC, Portaluppi F. Biological rhythms, drug delivery, and chronotherapeutics. In: Siepmann J, Siegel RA, Rathbone MJ, editors. Fundamentals and applications of controlled release drug delivery. Advances in delivery science and technology. New York: Springer; 2012. p. 359–443.CrossRef
5.
Zurück zum Zitat Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int. 2002;19(1):237–51 (Epub 2002/04/19).CrossRefPubMed Kobayashi M, Wood PA, Hrushesky WJ. Circadian chemotherapy for gynecological and genitourinary cancers. Chronobiol Int. 2002;19(1):237–51 (Epub 2002/04/19).CrossRefPubMed
6.
Zurück zum Zitat Hermida RC, Calvo C, Ayala DE, Covelo M, Rodriguez M, Lopez JE. Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens. 2005;18(S4):63A. Hermida RC, Calvo C, Ayala DE, Covelo M, Rodriguez M, Lopez JE. Administration time-dependent effects of nifedipine GITS on ambulatory blood pressure in patients with essential hypertension. Am J Hypertens. 2005;18(S4):63A.
7.
Zurück zum Zitat Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999–1010 (Epub 2003/10/30).CrossRefPubMed Ohdo S. Changes in toxicity and effectiveness with timing of drug administration: implications for drug safety. Drug Saf. 2003;26(14):999–1010 (Epub 2003/10/30).CrossRefPubMed
8.
Zurück zum Zitat Ji M, Li X-D, Zhang H, Ning Z-H, Zhang X, Zhao W-Q, et al. Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biol. 2014;35(12):12285–92.CrossRef Ji M, Li X-D, Zhang H, Ning Z-H, Zhang X, Zhao W-Q, et al. Report of clinical studies on chronochemotherapy for advanced non-small cell lung cancer in China. Tumor Biol. 2014;35(12):12285–92.CrossRef
9.
Zurück zum Zitat Youan B-BC. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004;98(3):337–53.CrossRefPubMed Youan B-BC. Chronopharmaceutics: gimmick or clinically relevant approach to drug delivery? J Control Release. 2004;98(3):337–53.CrossRefPubMed
10.
Zurück zum Zitat Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis. 2013;72(2):204–10.CrossRefPubMed Buttgereit F, Mehta D, Kirwan J, Szechinski J, Boers M, Alten RE, et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2). Ann Rheum Dis. 2013;72(2):204–10.CrossRefPubMed
11.
Zurück zum Zitat Kaur G, Phillips C, Wong K, Saini B. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm. 2013;35(3):344–58.CrossRefPubMed Kaur G, Phillips C, Wong K, Saini B. Timing is important in medication administration: a timely review of chronotherapy research. Int J Clin Pharm. 2013;35(3):344–58.CrossRefPubMed
12.
Zurück zum Zitat Strohl KP, Veasey S, Harding S, Skatrud J, Berger HA, Papp KK, et al. Competency-based goals for sleep and chronobiology in undergraduate medical education. Sleep. 2003;26(3):333–6 (Epub 2003/05/17).PubMed Strohl KP, Veasey S, Harding S, Skatrud J, Berger HA, Papp KK, et al. Competency-based goals for sleep and chronobiology in undergraduate medical education. Sleep. 2003;26(3):333–6 (Epub 2003/05/17).PubMed
13.
Zurück zum Zitat Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev. 2015;21:3–11.CrossRefPubMed Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: Cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev. 2015;21:3–11.CrossRefPubMed
14.
Zurück zum Zitat Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12–22.CrossRefPubMed Smolensky MH, Portaluppi F, Manfredini R, Hermida RC, Tiseo R, Sackett-Lundeen LL, et al. Diurnal and twenty-four hour patterning of human diseases: acute and chronic common and uncommon medical conditions. Sleep Med Rev. 2015;21:12–22.CrossRefPubMed
15.
Zurück zum Zitat Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–80.CrossRefPubMed Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood Press Monit. 2010;15(4):173–80.CrossRefPubMed
16.
Zurück zum Zitat Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 2015;21(6):773–90.CrossRefPubMed Smolensky MH, Hermida RC, Ayala DE, Portaluppi F. Bedtime hypertension chronotherapy: concepts and patient outcomes. Curr Pharm Des. 2015;21(6):773–90.CrossRefPubMed
17.
Zurück zum Zitat Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14(9):S280–90.CrossRef Smolensky MH, Haus E. Circadian rhythms and clinical medicine with applications to hypertension. Am J Hypertens. 2001;14(9):S280–90.CrossRef
19.
Zurück zum Zitat Yi-F Guo. Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J. 2003;145(5):779–86.CrossRef Yi-F Guo. Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. Am Heart J. 2003;145(5):779–86.CrossRef
20.
Zurück zum Zitat Ernst ME. Ambulatory blood pressure monitoring: recent evidence and clinical pharmacy applications. Pharmacotheraphy. 2013;33(1):69–83.CrossRef Ernst ME. Ambulatory blood pressure monitoring: recent evidence and clinical pharmacy applications. Pharmacotheraphy. 2013;33(1):69–83.CrossRef
21.
Zurück zum Zitat Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007;59(9):923–39.CrossRefPubMed Hermida RC, Ayala DE, Calvo C, Portaluppi F, Smolensky MH. Chronotherapy of hypertension: administration-time-dependent effects of treatment on the circadian pattern of blood pressure. Adv Drug Deliv Rev. 2007;59(9):923–39.CrossRefPubMed
22.
Zurück zum Zitat Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165–73.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol. 2011;58(11):1165–73.CrossRefPubMed
23.
Zurück zum Zitat Hermida RC, Ayala DE, Fernández JR, Mojón A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30(1–2):68–86.CrossRefPubMed Hermida RC, Ayala DE, Fernández JR, Mojón A. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30(1–2):68–86.CrossRefPubMed
24.
Zurück zum Zitat Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, et al. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 2013;30(1–2):176–91.CrossRefPubMed Hermida RC, Ayala DE, Crespo JJ, Mojón A, Chayán L, Fontao MJ, et al. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Chronobiol Int. 2013;30(1–2):176–91.CrossRefPubMed
25.
Zurück zum Zitat Hermida RC, Ayala DE, Mojón A, Fernández JR. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 2013;30(1–2):315–27.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications. Chronobiol Int. 2013;30(1–2):315–27.CrossRefPubMed
26.
Zurück zum Zitat Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1–2):145–58.CrossRefPubMed Mojón A, Ayala DE, Piñeiro L, Otero A, Crespo JJ, Moyá A, et al. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int. 2013;30(1–2):145–58.CrossRefPubMed
27.
Zurück zum Zitat Guidelines for the clinical use of. 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76(2):508–19 (Epub 2012/01/11).CrossRef Guidelines for the clinical use of. 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): digest version. Circ J. 2012;76(2):508–19 (Epub 2012/01/11).CrossRef
28.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
29.
Zurück zum Zitat Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother. 2015;49(3):323–34 (Epub 2014/12/18).CrossRefPubMed Stranges PM, Drew AM, Rafferty P, Shuster JE, Brooks AD. Treatment of hypertension with chronotherapy: is it time of drug administration? Ann Pharmacother. 2015;49(3):323–34 (Epub 2014/12/18).CrossRefPubMed
30.
Zurück zum Zitat Smolensky MH. Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Findings of two 1996 Gallup surveys. Chronobiol Int. 1998;15(4):377–94 (Epub 1998/08/26).CrossRefPubMed Smolensky MH. Knowledge and attitudes of American physicians and public about medical chronobiology and chronotherapeutics. Findings of two 1996 Gallup surveys. Chronobiol Int. 1998;15(4):377–94 (Epub 1998/08/26).CrossRefPubMed
32.
Zurück zum Zitat Corbin J, Strauss A. Grounded theory methodology. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Beverly Hills: Sage; 1994. p. 273–85. Corbin J, Strauss A. Grounded theory methodology. In: Denzin NK, Lincoln YS, editors. Handbook of qualitative research. Beverly Hills: Sage; 1994. p. 273–85.
35.
Zurück zum Zitat Zhu LL, Zhou Q, Yan XF, Zeng S. Optimal time to take once-daily oral medications in clinical practice. Int J Clin Pract. 2008;62(10):1560–71.CrossRefPubMed Zhu LL, Zhou Q, Yan XF, Zeng S. Optimal time to take once-daily oral medications in clinical practice. Int J Clin Pract. 2008;62(10):1560–71.CrossRefPubMed
36.
Zurück zum Zitat Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.CrossRefPubMed Hassan A, Haefeli WE. Appropriateness of timing of drug administration in electronic prescriptions. Pharm World Sci. 2010;32(2):162–71.CrossRefPubMed
37.
Zurück zum Zitat Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162(3):192–204.CrossRefPubMed Piper MA, Evans CV, Burda BU, Margolis KL, O’Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: a systematic review for the US Preventive Services Task Force. Ann Intern Med. 2015;162(3):192–204.CrossRefPubMed
38.
Zurück zum Zitat Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30(1–2):99–115.CrossRefPubMed Ayala DE, Moyá A, Crespo JJ, Castiñeira C, Domínguez-Sardiña M, Gomara S, et al. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes. Chronobiol Int. 2013;30(1–2):99–115.CrossRefPubMed
39.
Zurück zum Zitat Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30(1–2):87–98.CrossRefPubMed Hermida RC, Ayala DE, Mojón A, Fernández JR. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level—the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30(1–2):87–98.CrossRefPubMed
40.
Zurück zum Zitat Crespo JJ, Moya A, Otero A, Dominguez-Sardiña M, Pousa L, Callejas PA, et al. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level: the Hygia Project. J Am Soc Hypertens. 2014;8(4):e49.CrossRef Crespo JJ, Moya A, Otero A, Dominguez-Sardiña M, Pousa L, Callejas PA, et al. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level: the Hygia Project. J Am Soc Hypertens. 2014;8(4):e49.CrossRef
41.
Zurück zum Zitat Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.CrossRefPubMed Hermida RC, Ayala DE. Chronotherapy with the angiotensin-converting enzyme inhibitor ramipril in essential hypertension: improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.CrossRefPubMed
42.
Zurück zum Zitat Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54(2):177–86.CrossRefPubMed Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, et al. Cardiovascular effects, pharmacokinetics, and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54(2):177–86.CrossRefPubMed
43.
Zurück zum Zitat Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):295–300.PubMed Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, et al. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol. 1993;31(6):295–300.PubMed
44.
Zurück zum Zitat Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15(2):205–11.CrossRefPubMed Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15(2):205–11.CrossRefPubMed
45.
Zurück zum Zitat De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 2013;24(8):698–706.CrossRefPubMed De Giorgi A, Menegatti AM, Fabbian F, Portaluppi F, Manfredini R. Circadian rhythms and medical diseases: does it matter when drugs are taken? Eur J Intern Med. 2013;24(8):698–706.CrossRefPubMed
46.
Zurück zum Zitat Lincoln YS, Guba EG. Naturalist inquiry. Beverly Hills: Sage; 1985. Lincoln YS, Guba EG. Naturalist inquiry. Beverly Hills: Sage; 1985.
47.
Zurück zum Zitat Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed Gill P, Stewart K, Treasure E, Chadwick B. Methods of data collection in qualitative research: interviews and focus groups. Br Dent J. 2008;204(6):291–5.CrossRefPubMed
49.
Zurück zum Zitat Lawrence J, Tar U. The use of grounded theory technique as a practical tool for qualitative data collection and analysis. Electron J Bus Res Methods. 2013;11(1):29–40. Lawrence J, Tar U. The use of grounded theory technique as a practical tool for qualitative data collection and analysis. Electron J Bus Res Methods. 2013;11(1):29–40.
50.
Zurück zum Zitat Creswell JW. Qualitative inquiry and research design: choosing among five approaches. 3rd ed. London: Sage; 2013. Creswell JW. Qualitative inquiry and research design: choosing among five approaches. 3rd ed. London: Sage; 2013.
51.
Zurück zum Zitat Cho JY, Lee E-H. Reducing confusion about grounded theory and qualitative content analysis: similarities and differences. Qual Rep. 2014;19(32):1–20. Cho JY, Lee E-H. Reducing confusion about grounded theory and qualitative content analysis: similarities and differences. Qual Rep. 2014;19(32):1–20.
52.
Zurück zum Zitat Alsaikhan MAA-EF, Alsubaie M, Aldosari SA, Alhamaad A. Antihypertensive medications and chronopharmacology: role of Saudi pharmacists in patient education. Int J Dev Res. 2015;5(3):3831–5. Alsaikhan MAA-EF, Alsubaie M, Aldosari SA, Alhamaad A. Antihypertensive medications and chronopharmacology: role of Saudi pharmacists in patient education. Int J Dev Res. 2015;5(3):3831–5.
53.
Zurück zum Zitat Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82 (Epub 2007/09/29).CrossRefPubMed Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82 (Epub 2007/09/29).CrossRefPubMed
54.
Zurück zum Zitat Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084–96 (Epub 1995/05/01).CrossRefPubMed Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immunol. 1995;95(5 Pt 2):1084–96 (Epub 1995/05/01).CrossRefPubMed
55.
Zurück zum Zitat Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241–7.CrossRefPubMed Mormont MC, Lévi F. Circadian-system alterations during cancer processes: a review. Int J Cancer. 1997;70(2):241–7.CrossRefPubMed
56.
Zurück zum Zitat Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726–33 (Epub 1990/09/01).CrossRefPubMed Quyyumi AA. Circadian rhythms in cardiovascular disease. Am Heart J. 1990;120(3):726–33 (Epub 1990/09/01).CrossRefPubMed
57.
Zurück zum Zitat Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075–80 (Epub 2002/11/14).CrossRefPubMedPubMedCentral Bellamy N, Sothern RB, Campbell J, Buchanan WW. Rhythmic variations in pain, stiffness, and manual dexterity in hand osteoarthritis. Ann Rheum Dis. 2002;61(12):1075–80 (Epub 2002/11/14).CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Hart FD, Taylor RT, Huskisson EC. Pain at night. Lancet. 1970;1(7652):881–4 (Epub 1970/04/25).CrossRefPubMed Hart FD, Taylor RT, Huskisson EC. Pain at night. Lancet. 1970;1(7652):881–4 (Epub 1970/04/25).CrossRefPubMed
59.
Zurück zum Zitat Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine. Ann N Y Acad Sci. 1991;618:166–81 (Epub 1991/01/01).CrossRefPubMed Lemmer B, Scheidel B, Behne S. Chronopharmacokinetics and chronopharmacodynamics of cardiovascular active drugs. Propranolol, organic nitrates, nifedipine. Ann N Y Acad Sci. 1991;618:166–81 (Epub 1991/01/01).CrossRefPubMed
60.
Zurück zum Zitat Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women’s health. J Womens Health. 2005;14(1):38–46.CrossRef Smolensky MH, Hermida RC, Haus E, Portaluppi F, Reinberg A. Biological rhythms, medication safety, and women’s health. J Womens Health. 2005;14(1):38–46.CrossRef
61.
Zurück zum Zitat Erkekoglu P, Baydar T. Chronopharmacodynamics of drugs in toxicological aspects: a short review for clinical pharmacists and pharmacy practitioners. J Res Pharm Pract. 2012;1(2):41.CrossRefPubMedPubMedCentral Erkekoglu P, Baydar T. Chronopharmacodynamics of drugs in toxicological aspects: a short review for clinical pharmacists and pharmacy practitioners. J Res Pharm Pract. 2012;1(2):41.CrossRefPubMedPubMedCentral
62.
Zurück zum Zitat Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer; 1992. Touitou Y, Haus E, editors. Biologic rhythms in clinical and laboratory medicine. Berlin: Springer; 1992.
63.
Zurück zum Zitat Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11s–21s (Epub 1996/04/01).CrossRefPubMed Smolensky MH. Chronobiology and chronotherapeutics. Applications to cardiovascular medicine. Am J Hypertens. 1996;9(4 Pt 3):11s–21s (Epub 1996/04/01).CrossRefPubMed
64.
Zurück zum Zitat Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.CrossRefPubMed Smolensky MH, Peppas NA. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Deliv Rev. 2007;59(9–10):828–51.CrossRefPubMed
65.
Zurück zum Zitat Ohdo S. Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. Adv Drug Deliv Rev. 2010;62(9–10):859–75.CrossRefPubMed Ohdo S. Chronotherapeutic strategy: rhythm monitoring, manipulation and disruption. Adv Drug Deliv Rev. 2010;62(9–10):859–75.CrossRefPubMed
66.
Zurück zum Zitat Lee KA, Landis C, Chasens ER, Dowling G, Merritt S, Parker KP, et al. Sleep and chronobiology: recommendations for nursing education. Nurs Outlook. 2004;52(3):126–33.CrossRefPubMed Lee KA, Landis C, Chasens ER, Dowling G, Merritt S, Parker KP, et al. Sleep and chronobiology: recommendations for nursing education. Nurs Outlook. 2004;52(3):126–33.CrossRefPubMed
67.
Zurück zum Zitat Strohl KP, Haponik EE, Sateia MJ, Veasy S, Chervin RD, Zee P, et al. The need for a knowledge system in sleep and chronobiology. Acad Med. 2000;75(8):819–21.CrossRefPubMed Strohl KP, Haponik EE, Sateia MJ, Veasy S, Chervin RD, Zee P, et al. The need for a knowledge system in sleep and chronobiology. Acad Med. 2000;75(8):819–21.CrossRefPubMed
68.
Zurück zum Zitat Costa de Sousa I, de Lima Pereira, David J, Noblat LdACB. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ. 2013;77(4):80.CrossRefPubMedCentral Costa de Sousa I, de Lima Pereira, David J, Noblat LdACB. A drug information center module to train pharmacy students in evidence-based practice. Am J Pharm Educ. 2013;77(4):80.CrossRefPubMedCentral
69.
Zurück zum Zitat Puspitasari HP, Aslani P, Krass I. Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS ONE. 2014;9(11):e113337.CrossRefPubMedPubMedCentral Puspitasari HP, Aslani P, Krass I. Challenges in the care of clients with established cardiovascular disease: lessons learned from Australian community pharmacists. PLoS ONE. 2014;9(11):e113337.CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30(2):253–66.CrossRefPubMed Head GA, McGrath BP, Mihailidou AS, Nelson MR, Schlaich MP, Stowasser M, et al. Ambulatory blood pressure monitoring in Australia: 2011 consensus position statement. J Hypertens. 2012;30(2):253–66.CrossRefPubMed
71.
Zurück zum Zitat Culverhouse S, Wohlmuth H. Factors affecting pharmacists’ recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12(1):183.CrossRefPubMedPubMedCentral Culverhouse S, Wohlmuth H. Factors affecting pharmacists’ recommendation of complementary medicines—a qualitative pilot study of Australian pharmacists. BMC Complement Altern Med. 2012;12(1):183.CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Social Adm Pharm. 2009;5(3):197–210.CrossRefPubMed Puspitasari HP, Aslani P, Krass I. A review of counseling practices on prescription medicines in community pharmacies. Res Social Adm Pharm. 2009;5(3):197–210.CrossRefPubMed
73.
Zurück zum Zitat Hanes CA, Wong KK, Saini B. Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience. Int J Clin Pharm. 2014;36(2):460–8.CrossRefPubMed Hanes CA, Wong KK, Saini B. Clinical services for obstructive sleep apnea patients in pharmacies: the Australian experience. Int J Clin Pharm. 2014;36(2):460–8.CrossRefPubMed
Metadaten
Titel
Chronotherapy in practice: the perspective of the community pharmacist
verfasst von
Gagandeep Kaur
Yuh-Lin Gan
Craig L Phillips
Keith Wong
Bandana Saini
Publikationsdatum
01.02.2016
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 1/2016
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-015-0228-7

Weitere Artikel der Ausgabe 1/2016

International Journal of Clinical Pharmacy 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.